Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Liraglutide, a human GLP-1 ana...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss
Bibliographic Details
Main Authors:
Schmidt, W
,
Gough, S
,
Madsbad, S
,
Zinman, B
,
Falahati, A
,
Toft, A
,
Sesti, G
Format:
Conference item
Published:
2009
Holdings
Description
Similar Items
Staff View
Description
Summary:
Similar Items
Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c)
by: Gough, S, et al.
Published: (2010)
Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme.
by: Zinman, B, et al.
Published: (2012)
Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme
by: Zinman, B, et al.
Published: (2012)
Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes
by: Matthews, DR, et al.
Published: (2008)
The imaging of insulinomas using a radionuclide-labelled molecule of the GLP-1 analogue liraglutide: a new application of liraglutide.
by: Jing Lv, et al.
Published: (2014-01-01)